Bio-Techne (TECH) reported fiscal Q1 adjusted earnings Wednesday of $0.42 per diluted share, up from $0.41 a year earlier.
Analysts polled by Capital IQ expected $0.38.
Net sales for the quarter ended Sept. 30 were $289.5 million, up from $276.9 million a year earlier.
Analysts surveyed by Capital IQ expected $280.1 million.
Separately, the company maintained its quarterly dividend at $0.08 per share, payable Nov. 22 to shareholders of record on Nov. 11.
Shares of the company rose 4.6% in recent premarket activity.
Price: 73.99, Change: +3.25, Percent Change: +4.59